TAUNS Laboratories,Inc.

¥476.00As of Sun 8 Nov 2026, 12:00 UTC
TSE:197AHealthcare
Country Japan
PE (Fwd) •••
TSR 2Y CAGR 11.49%
Div yield 6.09%
ROE 29.83%
Medical Devices
Beta (5Y) 0.70
PE TTM 9.319
TSR TTM (9.22%)
Mkt cap ¥50.84B
ROIC 8.44%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥500
5.09%
(85.53%)
Hold 9|6|9|3|10
2Q26
3Q26
4Q26
1Q27
Earnings per share¥
4.45
4.58
4.96
5.20
3.55%
12.07%
18.86%
23.73%
Revenue¥B
2.327
2.272
2.211
2.222
2.30%
2.73%
(3.22%)
0.12%
Peers (US$322.8M)
Cap (US$)
PE
291.0M
10.43x
263.6M
14.02x
244.0M
139.2x
321.2M
25.74x
Capital
TTM
5Y
10Y
Leveragex
0.249
0.059
0.045
EBIT/Intx
1.010
0.512
0.569
Own earn%
(30.18)
16.98
4.76
Sh yield%
35.37
34.44
33.58
Owners
Insiders/Inst%
1.56
33.42
Short interest%
2.73
SBC / revenue%
4.97
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
12
Op margin range%
6–12
$1 testx
—
Incr. ROIC%
0